Skip to content

Net margin at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
28.2%-0.3pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
104.3%+71.4pp
LQD
Liquidia CorporationLQDA
-176.2%-76.4pp
United Therapeutics logo
United TherapeuticsUTHR
40.6%+0.2pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
5.2%-0.1pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
101.6%+60.1pp

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

Based on trailing twelve months.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's net margin?
Pulmonx Corporation (LUNG) reported net margin of -60.1% in Q1 2026.
How has Pulmonx Corporation's net margin changed year-over-year?
Pulmonx Corporation's net margin increased by 7.9% year-over-year, from -65.3% to -60.1%.
What is the long-term trend for Pulmonx Corporation's net margin?
Over 5 years (2020 to 2025), Pulmonx Corporation's net margin has grown at a -9.5% compound annual growth rate (CAGR), from -98.5% to -59.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.